Perspective · 10 Sep 2026
Conference abstractPublished 22 Oct 2012
Association analysis between HLA-DRB1 allelic polymorphisms and age to identify genes promoting the early onset of solid cancers
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
To explore relationships between the early-onset solid cancer and HLA-DRB1 allelic polymorphism and develop an efficient research method for identifying early onset solid cancer-related genes. Patients with different solid cancers, including gastric, liver, and lung cancers, were recruited as the cancer group. On the basis of their age at the time of the first surgery, 70 patients were divided into the following 7 age groups with 5 males and 5 females in each group: < 50 years, 50?54 years, 55?59 years, 60?64 years, 65?69 years, 70?74 years, and 75?79 years. The 70 healthy subjects, who were also divided into 7 age groups as was the cancer group, were served as the control group. The samples were typed using an HLA-DRB1 PCR-SSP typing kit. The mean age of patients and healthy subjects with and without the alleles was calculated respectively. In the cancer group, the mean age of patients with HLA-DRB1*01 (52.5 years old) was less than that of patients without this allele (62.1 years old). There was an interaction between the mean age of patients in both groups (cancer and control) and the genes (positive and negative expression; p < 0.05). HLA-DRB1 alleles may be involved in the pathogenesis of early-onset solid cancer. The inherent anti-cancer mechanisms may be a common pathway for different cancers and are associated with the immune system and HLA.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Liu Hui”
